Skip to main content
Clinical Trials/ITMCTR2000004108
ITMCTR2000004108Not yet recruitingPhase 1

Clinical study of Huanglian Jiedu Decoction in improving the efficacy of septic cardiomyopathy patients

Renji Hospital, School of Medicine, Shanghai Jiao Tong University0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 70 (—)
Sex
All

Inclusion Criteria

  • 1. Meet the diagnostic criteria for sepsis;
  • 2. Aged between 18 and 70 years;
  • 3. Meet the diagnostic criteria of sepsis cardiomyopathy;
  • 4. Those who meet the standard of TCM syndrome differentiation and classification of heat poison;
  • 5. Volunteer for the test.

Exclusion Criteria

  • 1. Pregnant or lactating women;
  • 2. Mental disorder or unwillingness to cooperate;
  • 3. Patients with primary heart disease;
  • 4. Patients with severe primary diseases and malignant tumors of liver and kidney, blood, endocrine system, etc.

Investigators

Sponsor
Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Similar Trials